In-vitro effects of penicillin and clindamycin on the expression of Streptococcus pneumoniae capsule

References

1. Nelson C. T., Mason E. O., Kaplan S. L. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J 1994; 13:585–589
   [Google Scholar]
2. Klugman K. P., Koomhof H. J. Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979–1986. J Infect Dis 1988; 158:956–964
   [Google Scholar]
3. Appelbaum P. C. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15:77–83
   [Google Scholar]
4. Block S. L., Harrison C. J., Hedrick J. A. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995; 14:751–759
   [Google Scholar]
5. Musher D. M., Johnson B., Watson D. A. Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4. Infect Immun 1990; 58:3871–3876
   [Google Scholar]
6. Watson D. A., Musher D. M. Interruption of capsule production in Streptococcus pneumoniae serotype 3 by insertion of transposon Tn916 . Infect Immun 1990; 58:3135–3138
   [Google Scholar]
7. Murray P. R., Baron E. J., Pfaller M. A., Tenover F. C., Yolken R. H. (eds) Manual of clinical microbiology 6th edn Washington, DC: American Society for Microbiology; 1995
   [Google Scholar]
8. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7–A3. Villanova, PA: National Committee for Clinical Laboratory Standards; 1995
   [Google Scholar]
9. Holloway Y., Boersma W. G., Kuttschrütter H., Snijder J. A. M. Detection of pneumococcal capsular antigen in the presence of penicillin in vitro. Scand J Infect Dis 1993; 25:317–322
   [Google Scholar]
10. Brook I., Gober A. E., Leyva F. In vitro and in vivo effects of penicillin and clindamycin on expression of group A beta-hemolytic streptococcal capsule. Antimicrob Agents Chemother 1995; 39:1565–1568
    [Google Scholar]
11. Milatovic D., Braveny J., Verhoef J. Clindamycin enhances opsonization of Staphylococcus aureus . Antimicrob Agents Chemother 1983; 24:413–417
    [Google Scholar]
12. Yokoi H., Murahashi K., Yanagita N., Deguchi K. Study of tissue concentration of clindamycin-2-phosphate and its clinical usefulness. Pract Otol (Kyoto) 1985; 78:2891–2896
    [Google Scholar]
13. Feigin R. D., Keeney R. E., Nusrala J., Shackleford P. G., Lins R. D. Efficacy of clindamycin therapy for otitis media. Arch Otolaryngol 1973; 98:27–31
    [Google Scholar]
14. Brook I. Management of chronic suppurative otitis media: superiority of therapy effective against anaerobic bacteria. Pediatr Infect Dis J 1994; 13:188–193
    [Google Scholar]